Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

One of the joys of browsing secondhand shops is the possibility of finding old, perhaps restorable or hackable, electronics at low prices. Admittedly, they usually seem to be old flat-screen TVs, ...

Finding the right book can make a big difference, especially when you’re just starting out or trying to get better. We’ve ...